Cellcys Labs Private Limited
About Cellcys Labs Private Limited
Data last updated:
Cellcys Labs Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Samarth Pharma Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 17 October 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2013PTC249295. Its GSTIN is 27AAFCC5153N1ZC (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹1.71 Cr. It is led by directors Rajiv Gunvantlal Shah and Pranav Gunvantlal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹82.63 Lakh, a decline of 72% compared to the previous year. For the same year it recorded a net profit of ₹51.72 Lakh (net margin 62.6%) and EBITDA of ₹62.24 Lakh (EBITDA margin 75.3%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 9% over five years.
The company has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹70.1 Lakh; the latest was in March 2015.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cellcys Labs Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address301 Samarth House Yoga Niketan Road Bangur Ngr Plot No. 167 Nr. Ayyappa Te, Mple, Mumbai, Maharashtra, India – 400090
- IndustryPharma, Pharma Contract R&D, Drug Formulation & Development
To see the full contact details of Cellcys Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Cellcys Labs are professional, scientific and technical and trade. In detail, this covers other professional, scientific and technical activities and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cellcys Labs Private Limited, buy the company report.
Financials of Cellcys Labs Private Limited
FY 2025 filings availableCellcys Labs Private Limited reported revenue of ₹82.63 Lakh (down 72% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 72% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹62.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹51.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 75.3% | ||||
| Net Profit Margin | 62.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cellcys Labs Private Limited, buy the company report.
Board of directors of Cellcys Labs Private Limited
Cellcys Labs has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Gunvantlal Shah Also directs: Khanuja Estates LLP, Samarth Life Sciences Private Limited, Money Honey Financial Services Private Limited and 4 more | Director | 17 Dec 2013 | 12 Years 10 Months | Current |
| Pranav Gunvantlal Shah | Director | 17 Dec 2013 | 12 Years 10 Months | Current |
Auditor
Cellcys Labs Private Limited is audited by Satish Soni & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Satish Soni & Co. | FY 2023 | 044391 |
Shareholding
The shareholding of Cellcys Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cellcys Labs Private Limited, buy the company report.
Deals & funding
Cellcys Labs Private Limited has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹70.1 Lakh; the latest was in March 2015.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Rights issue | ₹1 Cr | Investors: Samarth Pharma Private Limited , an individual |
| Mar 2014 | Funding round | ₹70.1 Lakh | Investors: Samarth Pharma Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Cellcys Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cellcys Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cellcys Labs has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCC5153N1ZC | Maharashtra | Active | 01 Jul 2017 |
| 02AAFCC5153N1ZO | Himachal Pradesh | Active | 26 Jun 2021 |
To see the full GST registrations and return filing status of Cellcys Labs Private Limited, buy the company report.
Recent activity
Cellcys Labs Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Avinash Anand Shejale ceased to be Director on 01 Jun 2019.
Frequently asked questions
Cellcys Labs is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 17 October 2013 (13+ years old) and is registered under CIN U85100MH2013PTC249295.
Cellcys Labs has 2 current directors:
- Rajiv Gunvantlal Shah - Director
- Pranav Gunvantlal Shah - Director
The latest financial statements of Cellcys Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cellcys Labs is 27AAFCC5153N1ZC, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AAFCC5153N1ZO (Himachal Pradesh).
The CIN (Corporate Identification Number) of Cellcys Labs is U85100MH2013PTC249295. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cellcys Labs was incorporated on 17 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Cellcys Labs has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹70.1 Lakh; the latest was in March 2015.
Avinash Anand Shejale ceased to be Director on 01 Jun 2019. Keyur Chandrashekhar Dave ceased to be Director on 18 Dec 2013. Vikram Shripalraj Lalwani ceased to be Director on 18 Dec 2013. Cellcys Labs has 5 board changes on record in total.
The registered office of Cellcys Labs is at 301 Samarth House Yoga Niketan Road Bangur Ngr Plot No. 167 Nr. Ayyappa Te, Mple, Mumbai, Maharashtra, India – 400090.
Cellcys Labs operates in the pharma industry, in the pharma contract r and d segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
